throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________
`
`
`AMERICAN NATIONAL MANUFACTURING INC.,
`Petitioner,
`
`v.
`
`SLEEP NUMBER CORPORATION
`f/k/a SELECT COMFORT CORPORATION,
`Patent Owner.
`____________
`
`Case No. IPR2019-00514
`Patent No. 5,904,172
`____________
`
`
`
`
`
`
`PATENT OWNER’S OPPOSITION TO
`PETITIONER’S MOTION TO EXCLUDE
`
`
`
`
`
`
`
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`
`
`
`TABLE OF CONTENTS
`
`INTRODUCTION ................................................................................................. 1
`STANDARD ......................................................................................................... 1
`ARGUMENT......................................................................................................... 2
`
`Exhibit 2041 – Declaration of Dr. John Abraham. ............................. 2
`
`Exhibits 2043–2053 –Third-Party Air Controller Claim Charts. ........ 4
` Exhibit 2054 – Declaration of Dr. George Edwards. .......................... 5
` Exhibit 2055 – Declaration of Carl Degen. ........................................ 6
`Exhibit 2058 – Declaration of Elizabeth A. Patton. ............................ 7
`
` Exhibit 2059 – Trial Transcript from Dires Case...............................11
` Exhibits 2060 – Dires Business Records. ..........................................12
` Exhibit 2061 – Dires Emails. ............................................................14
` Exhibits 2070–2075 – Infringement Contentions. .............................14
`
`Exhibit 2084 – Optimus Emails. .......................................................15
`CONCLUSION ....................................................................................................15
`
`
`
`
`
`
`i
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`
`Cases
`
`TABLE OF AUTHORITIES
`
` Page(s)
`
`Acrux DDS PTY Ltd. v. Kaken Pharm. Co. Ltd.,
`IPR2017-00190, Paper 81 (PTAB June 6, 2018) ................................................ 8
`
`Aver Info. Inc. v. Pathway Innovations & Techs., Inc.,
`IPR2017-02108, Paper 31 (PTAB Mar. 6, 2019) ............................................... 4
`
`The Braun Corp. v. Maxon Lift Corp.,
`282 F. Supp. 2d 931 (N.D. Ind. 2003), aff’d sub nom. Braun Corp.
`v. Maxon Lift Corp., 97 F. App’x 335 (Fed. Cir. 2004) ...................................... 3
`
`Carta v. Lumbermens Mut. Cas. Ins. Co.,
`419 F. Supp. 2d 23 (D. Mass. 2006) ................................................................. 10
`
`Cisco Sys., Inc., v. Centripetal Networks, Inc.,
`IPR2018-01512, Paper 32 (PTAB Mar. 19, 2020).............................................. 9
`
`CIT Bank N.A. v. Elliott,
`No. 15-CV-4395(JS)(ARL), 2018 WL 1701947 (E.D.N.Y. Mar. 31, 2018) ....... 8
`
`Comcast Cable Comm’n, LLC v. Promptu Sys. Corp.,
`IPR2018-00343, Paper 56 (PTAB July 18, 2019)............................................. 14
`
`Comput. Sys. Eng’g, Inc. v. Qantel Corp.,
`740 F.2d 59 (1st Cir. 1984) ........................................................................ 11, 15
`
`Conoco Inc. v. Dept. of Energy,
`99 F.3d 387 (Fed. Cir. 1996) ............................................................................ 13
`
`Demaco Corp. v. F. Von Langsdorff Licensing Ltd.,
`851 F.2d 1387 (Fed. Cir. 1988) .......................................................................... 6
`
`Ericsson v. Intellectual Ventures I LLC,
`IPR2014-00527, Paper 41 (PTAB May 18, 2015) ............................................ 13
`
`FedEx Corp. v. Intellectual Ventures, LLC,
`IPR2017-00859, Paper 45 (PTAB Aug. 9, 2018) ............................................... 8
`
`ii
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`Flir Sys., Inc. v. Leak Surveys, Inc.,
`IPR2014-00411, Paper 113 (PTAB Sept. 3, 2015) ............................................. 1
`
`HTC Corp. v. Advanced Auto Devices, LLC,
`IPR2014-01155, Paper 36 (PTAB Dec. 29, 2015) .................................. 1, 10, 13
`
`Hutchinson Tech. Inc. v. Nitto Denko Corp.,
`IPR2017-01421, Paper 52 (PTAB Oct. 10, 2018) .............................................. 9
`
`Incyte Corp. v. Concert Pharm., Inc.,
`IPR2017-01256, Paper 119 (PTAB Apr. 8, 2019) .................................. 2, 5, 7, 9
`
`Juniper Networks, Inc. v. Chrimar Sys., Inc.,
`IPR2016-01397, Paper 66 (PTAB Dec. 29, 2017) ............................................ 13
`
`Lizanetz v. St. Paul Guardian Ins. Co.,
`No. 3-07-CV-0123-BD, 2008 WL 4865581 (N.D. Tex. Nov. 10, 2008) ............. 7
`
`Masterimage 3d, Inc. v. RealD Inc.,
`IPR2015-00040, Paper 85 (PTAB Apr. 14, 2016) .................................... 2, 8, 10
`
`Nippon Suisan Kaisha Ltd. v. Pronova Biopharma Norge As,
`PGR2017-00033, Paper 37 (PTAB Jan. 16, 2019) ............................................. 4
`
`Palo Alto Networks, Inc. v. Finjan, Inc.,
`IPR2015-01979, Paper 27 (PTAB Aug. 11, 2016) ............................................. 1
`
`Polygroup Ltd. v. Willis Elec. Co.,
`IPR2016-01610, Paper 187 (PTAB Feb. 26, 2018) .......................................... 14
`
`Provepharm Inc. v. Wista Labs. Ltd.,
`IPR2018-00323, Paper 49 (PTAB July 2, 2019) .............................................. 12
`
`Renesas Elecs. Corp. v. Lone Star Silicon Innovations, LLC,
`IPR2017-01869, Paper 33 (PTAB Mar. 25, 2019).............................................. 3
`
`Schiedmayer Celesta Gmbh v. Piano Factory Grp.,
`No. CANCELLATION 9206121, 2016 WL 8222575 (TTAB Dec. 21, 2016) . 10
`
`Sleep Number Corp. v. John Baxter, et al.,
`12-cv-2899-DF-SER (D. Minn. 2012) ............................................................. 11
`
`iii
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`Sleep Number Corp. v. John Baxter, et al.,
`19-1077 (8th Cir. 2019) ....................................................................... 11, 13, 14
`
`Toyota Motor Corp. v. Blitzsafe Tx., LLC,
`IPR2016-00418, Paper 16 (PTAB Aug. 2, 2016) ............................................... 1
`
`Universal Safety Response, Inc. v. Secure USA, Inc.,
`No. 08CIV4851LTSDCF, 2010 WL 11595035 (S.D.N.Y. Apr. 27, 2010) ....... 11
`
`Other Authorities
`
`37 C.F.R. § 11.307 ................................................................................................ 10
`
`37 C.F.R. § 42.20(c) ............................................................................................... 1
`
`37 C.F.R. § 42.64 .................................................................................... 1, 4, 10, 13
`
`37 C.F.R. § 42.65(a) ......................................................................................... 4, 15
`
`77 Fed. Reg. 48,756 (Aug. 14, 2012) ...................................................................... 7
`
`Fed. R. Evid. 602 ................................................................................................ 8, 9
`
`Fed. R. Evid. 701 .................................................................................................... 9
`
`Fed. R. Evid. 702 .................................................................................................... 6
`
`Fed. R. Evid. 703 .......................................................................................... 4, 5, 15
`
`Fed. R. Evid. 801 ...................................................................................... 11, 12, 15
`
`Fed. R. Evid. 802 .................................................................................................... 4
`
`Fed. R. Evid. 803 ............................................................................................ 11, 13
`
`Fed. R. Evid. 901 ............................................................................................ 11, 13
`
`
`
`iv
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`
`INTRODUCTION
`
`Petitioner American National Manufacturing, Inc. (“ANM”) has failed to
`
`satisfy its burden in establishing that any of the evidence subject to its Motion to
`
`Exclude is inadmissible under the Federal Rules of Evidence (“FRE”). Patent Owner
`
`Sleep Number Corporation (“PO”) respectfully requests that the Board deny
`
`exclusion of Exs. 2041, 2043–2055, 2058–2061, 2070–2075, and 2084. (See
`
`Petitioner’s Motion to Exclude Evidence, Paper 83 (“Pet.’s MTE”).)
`
`STANDARD
`
`The party bringing a motion to exclude “has the burden of proof to establish
`
`that it is entitled to the requested relief.” Flir Sys., Inc. v. Leak Surveys, Inc.,
`
`IPR2014-00411, Paper 113 at 3 (PTAB Sept. 3, 2015) (citing 37 C.F.R. § 42.20(c)).
`
`A party cannot base a motion to exclude on evidentiary grounds it did not previously
`
`assert in its objections. See 37 C.F.R. § 42.64; HTC Corp. v. Advanced Auto Devices,
`
`LLC, IPR2014-01155, Paper 36 at 26 (PTAB Dec. 29, 2015).
`
`In opposing a motion to exclude, a party who previously served supplemental
`
`evidence “may file the supplemental evidence with [its] Opposition to the Motion,”
`
`Palo Alto Networks, Inc. v. Finjan, Inc., IPR2015-01979, Paper 27 at 2 (PTAB Aug.
`
`11, 2016), in order to “support admissibility of the originally filed evidence and to
`
`defeat a Motion to Exclude that evidence,” Toyota Motor Corp. v. Blitzsafe Tx., LLC,
`
`IPR2016-00418, Paper 16 at 7 (PTAB Aug. 2, 2016). If the supplemental evidence
`
`1
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`cures the objection at issue, the motion to exclude should be denied. Masterimage
`
`3d, Inc. v. RealD Inc., IPR2015-00040, Paper 85 at 68 (PTAB Apr. 14, 2016) (“On
`
`this record, the deficiency alleged by Petitioner has been obviated by [PO’s]
`
`Supplemental Evidence. Accordingly, [the] Motion to Exclude is denied.”).1
`
`Exhibit 2041 – Declaration of Dr. John Abraham.
`
`ARGUMENT
`
`
`
`Abraham submitted a detailed, well-supported declaration in which he opined
`
`that ANM’s, Sizewise’s, and third-parties’ products practice the ‘172 Patent by
`
`copying PO’s products. To the extent it is relevant, ANM’s critique that Abraham
`
`did not operate or test a pump or air mattress “in this proceeding” simply goes to the
`
`weight to be given his opinions, not the admissibility. See Incyte Corp. v. Concert
`
`Pharm., Inc., IPR2017-01256, Paper 119 at 44 (PTAB Apr. 8, 2019) (denying
`
`motion to exclude because objections “implicate the weight and sufficiency of the
`
`testimony, rather than its admissibility”). Abraham, who has extensive training and
`
`
`1 Here, PO timely served ANM with Supplemental Declarations of John Abraham,
`
`George Edwards, Carl Degen, and Elizabeth Patton, which cured any purported
`
`objections by ANM and which are being filed herewith. (See Supp. Exs. 2041, 2054,
`
`2055, 2058.) Accordingly, ANM’s motion is moot. See Masterimage 3d, Inc.,
`
`IPR2015-00040, Paper 85 at 68.
`
`2
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`experience in mechanical engineering, need not physically operate, assemble, and/or
`
`test a pump or air mattress in order to understand how it works. (Ex. 1065 at 168:22–
`
`169:3.) Further, he has many years of experience analyzing the very products at issue
`
`here. (Supp. Ex. 2041, ¶¶7–12.) See The Braun Corp. v. Maxon Lift Corp., 282 F.
`
`Supp. 2d 931, 933–34 (N.D. Ind. 2003), aff'd sub nom. Braun Corp. v. Maxon Lift
`
`Corp., 97 F. App'x 335 (Fed. Cir. 2004) (admitting expert opinion due to expert’s
`
`multiple years of experience in field at issue). Indeed, Abraham has served as an
`
`expert in multiple litigations involving the ‘172 Patent, conducted numerous
`
`physical inspections (including physically operating the products), and taken images
`
`of competitor products, including several of ANM’s products. (Ex. 1065 at 164:2–
`
`168:20; Supp. Ex. 2041 ¶¶8–10.) See Renesas Elecs. Corp. v. Lone Star Silicon
`
`Innovations, LLC, IPR2017-01869, Paper 33 at 12–13 (PTAB Mar. 25, 2019)
`
`(finding opinion admissible due to expert’s experience with relevant technology).
`
`ANM’s contention that Abraham’s opinions merely adopt attorney argument
`
`is also unsupported and contradicted by the record. Abraham testified he took the
`
`photographs used in PO’s district court infringement contentions and personally
`
`agreed with those contentions when developing his opinions. (Ex. 1065 at 106:20–
`
`107:19, 170:16–172:4; Supp. Ex. 2041 ¶¶42–46.) Further, Abraham testified that he
`
`personally analyzed the third-party products and prepared the claim charts
`
`comprising Exs. 2043–2053. (Ex. 1065 at 150:16–152:13; Supp. Ex. 2041 ¶48.)
`
`3
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`Even so, such argument goes to weight, not admissibility. See Aver Info. Inc. v.
`
`Pathway Innovations & Techs., Inc., IPR2017-02108, Paper 31 at 60 (PTAB Mar.
`
`6, 2019) (denying motion to exclude because objections to purported attorney
`
` Exhibits 2043–2053 –Third-Party Air Controller Claim Charts.
`
`argument go to weight, not admissibility, of evidence).
`
`ANM’s arguments related to Exs. 2043–2053 are unsupported and untimely.
`
`Again, and contrary to ANM’s claims, Abraham prepared Exs. 2043–2053. (Ex.
`
`1065 at 150:16–152:13; Supp. Ex. 2041 ¶ 48.) Also, ANM’s hearsay argument has
`
`been waived as ANM did not timely object under FRE 802. (See Paper 52 at 10–31.)
`
`See 37 C.F.R. § 42.64(b)(1), (c); Nippon Suisan Kaisha Ltd. v. Pronova Biopharma
`
`Norge As, PGR2017-00033, Paper 37 at 56 (PTAB Jan. 16, 2019) (holding
`
`objections made for the first time in a motion to exclude are waived). Regardless,
`
`the charts are not being offered to show the truth of their contents—i.e.
`
`infringement—but rather to demonstrate the factual basis for Abraham’s opinion that
`
`the ‘172 Patent has value and that PO’s technology was copied by the industry. (See
`
`Ex. 2041 ¶¶47–48.) See also FRE 703 (underlying facts need not be admissible for
`
`expert’s opinion based upon facts to be admitted). Lastly, the exhibits do not
`
`circumvent page limits or incorporate by reference—they simply disclose the
`
`underlying facts on which Abraham’s opinion is based. See 37 C.F.R. § 42.65(a).
`
`4
`
`

`

` Exhibit 2054 – Declaration of Dr. George Edwards.
`
`Case IRP2019-00514
`Patent 5,904,172
`
`
`Edwards submitted a detailed, well-supported declaration in which he opined
`
`that ANM’s source code practices the ‘172 Patent and copies PO’s source code.
`
`ANM’s critiques that Edwards relies upon source code not filed in this proceeding
`
`and that his opinions are conclusory go only to the weight to be given his opinions,
`
`not their admissibility, as there is no requirement that the underlying source code be
`
`admitted or even admissible. See FRE 703 (underlying facts need not be admissible
`
`for expert’s opinion based upon facts to be admitted); see also Incyte Corp.,
`
`IPR2017-01256, Paper 119 at 44 (objections go to weight, not admissibility).
`
`Regardless, Edwards provided detailed analysis of the operation of both parties’
`
`source code. With respect to PO’s source code, Edwards explained its operation and
`
`described his methodology at length in both his original declaration and now-
`
`operative supplemental declaration. (See Ex. 2054 ¶¶20–28, 33–34; Supp. Ex. 2054
`
`¶¶20–28, 33–34.) Edwards did the same with respect to ANM’s source code. (See
`
`Ex. 2054 ¶¶35–40; Supp. Ex. 2054 ¶¶35–40.) Further, Edwards provided charts
`
`explaining which elements of the ‘172 Patent are satisfied by ANM’s source code
`
`and explained that he drafted and agreed with PO’s district court infringement
`
`contentions, the unredacted versions of which ANM used during Edwards’
`
`deposition. (See Supp. Ex. 2054 ¶¶33–41, Table 3; see also Pet.’s MTE at 6
`
`(acknowledging that Edwards provided unredacted versions).) PO’s unredacted
`
`5
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`contentions provide specific, i.e., by line number and variable, detail regarding how
`
`elements of the ‘172 Patent are satisfied by ANM’s source code and are anything
`
`but conclusory as ANM contends. (See Supp. Ex. 2054 ¶20.)
`
`To the extent ANM still questioned Edwards’ “thought process” after
`
`reviewing his original and supplemental declaration, ANM took his deposition,
`
`where he explained how he reached his conclusions concerning the source code’s
`
`operation with to-the-line-number precision. (E.g., Ex. 1055 at 259:10–264:15;
`
`283:18–285:15.) Dr. Edwards’ opinions are based on specialized knowledge helpful
`
`to the issues, sufficient facts, and a reasonable application of reliable principles and
`
` Exhibit 2055 – Declaration of Carl Degen.
`
`methods to the facts of the case, making them admissible. See FRE 702.
`
`Degen submitted a detailed, well-supported declaration in which he opined
`
`that ANM’s unit data supports a finding of commercial success. ANM’s objections
`
`to his testimony are based on unsupported assertions: (1) ANM President Craig
`
`Miller’s late assertion that various sales were over/under counted and (2) Degen not
`
`controlling for every potential factor. Notably, Miller was the one who compiled the
`
`data (and timeline) that Degen analyzed, which Miller admitted Degen properly
`
`analyzed and counted. (See Ex. 2097 at 27:8–21, 30:16–35:15, 38:11–40:15, 53:8–
`
`19, 59:6–12, 95:8–97:10; see generally Ex. 1072.) Further, Degen was not required
`
`to control for every factor in preparing his expert opinion. See Demaco Corp. v. F.
`
`6
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`Von Langsdorff Licensing Ltd., 851 F.2d 1387, 1394 (Fed. Cir. 1988) (noting
`
`requirement for proof of “all imaginable contributing factors would be unfairly
`
`burdensome, and contrary to the ordinary rules of evidence”).2
`
`Ultimately, ANM’s objections to Degen’s testimony go to the weight, not the
`
`admissibility, of the evidence. See Incyte Corp., IPR2017-01256, Paper 119 at 44
`
`(denying motion to exclude because objections go to weight, not admissibility).
`
`ANM’s attempt to exclude Degen’s testimony in favor of its own expert’s testimony
`
`is simply an effort to engage in a “battle of experts,” which is inappropriate for a
`
`motion to exclude. See Lizanetz v. St. Paul Guardian Ins. Co., No. 3-07-CV-0123-
`
`BD, 2008 WL 4865581, at *1 (N.D. Tex. Nov. 10, 2008) (where qualified experts
`
`disagree, “battle of experts” should not be resolved by court on motion to exclude).
`
`Indeed, this attempt to argue the merits of the parties’ expert opinions is improper
`
`and premature. See Office Patent Trial Practice Guide, 77 Fed. Reg. 48,756, 48,767
`
`(Aug. 14, 2012) (noting a motion to exclude “may not be used to challenge the
`
` Exhibit 2058 – Declaration of Elizabeth A. Patton.
`
`sufficiency of the evidence to prove a particular fact”).
`
`
`2 Notably, none of ANM’s cited cases proscribes the standard articulated by ANM.
`
`(See Pet.’s MTE at 8.)
`
`7
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`
`Ex. 2058 is a counsel declaration authenticating various exhibits.3 ANM has
`
`not satisfied its burden to demonstrate that Ex. 2058 is inadmissible under FRE 602
`
`or 701. First, under FRE 602, a witness, including counsel, is competent to testify if
`
`she has personal knowledge of the matter. The entirety of Ex. 2058 is presented from
`
`PO’s counsel’s first-hand knowledge. (See Ex. 2058 ¶¶2 (attesting to first-hand
`
`knowledge), 4–9 (detailing involvement with prior ANM related trial), 11–15
`
`(noting capture of ANM and real party-in-interest Dires LLC’s (“Dires”) websites);
`
`see also Supp. Ex. 2058 ¶¶2, 4–9, 11–15 (same).) See FedEx Corp. v. Intellectual
`
`Ventures, LLC, IPR2017-00859, Paper 45 at 11–12 (PTAB Aug. 9, 2018) (denying
`
`FRE 602 motion to exclude because arguments did “not persuade us that [witness]
`
`lacks personal knowledge . . . based on a failure to directly witness specific events”);
`
`CIT Bank N.A. v. Elliott, No. 15-CV-4395(JS)(ARL), 2018 WL 1701947, at *5
`
`(E.D.N.Y. Mar. 31, 2018) (finding attorney affidavits admissible where based on
`
`
`3 The Supplemental Declaration of Elizabeth Patton is filed as Supp. Ex. 2058. ANM
`
`fails to mention that, in light of ANM’s concerns with Ex. 2058, the parties
`
`previously met and conferred, during which PO offered to expunge Ex. 2058 in favor
`
`of Supp. Ex. 2058. ANM never responded to that proposal, which is now mooted
`
`given ANM’s motion to exclude, which allows the filing and consideration of Supp.
`
`Ex. 2058. See Masterimage 3d, IPR2015-00040, Paper 85 at 68.
`
`8
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`personal observations and review of documents); Acrux DDS PTY Ltd. v. Kaken
`
`Pharm. Co. Ltd., IPR2017-00190, Paper 81 at 8 (PTAB June 6, 2018) (finding
`
`proffered declaration that websites are true and correct copies as sufficient
`
`authentication). Even so, a witness’ competency to testify is not grounds for
`
`exclusion. See, e.g., Incyte Corp., IPR2017-01256, Paper 119 at 44 (admitting
`
`evidence because FRE 602 objections “implicate the weight and sufficiency of the
`
`testimony, rather than its admissibility”).
`
`Pursuant to FRE 701, ANM failed to show that Ex. 2058’s testimony is not
`
`based on a witness’s perception, not helpful to determining a fact at issue, and based
`
`on scientific or technical knowledge. Rather, the exhibit simply sets forth undisputed
`
`facts and background information for purposes of authenticating various exhibits
`
`known to or located by the declarant or the declarant’s law office. Such testimony
`
`does not constitute improper lay opinion. See Cisco Sys., Inc., v. Centripetal
`
`Networks, Inc., IPR2018-01512, Paper 32 at 79 (PTAB Mar. 19, 2020) (finding
`
`testimony was not improper lay testimony because it concerned indisputable facts);
`
`Hutchinson Tech. Inc. v. Nitto Denko Corp., IPR2017-01421, Paper 52 at 40 (PTAB
`
`Oct. 10, 2018) (denying motion to exclude based on improper lay testimony, finding
`
`such arguments “go more to the weight of [witness’] testimony than its
`
`admissibility”). Regardless, ANM’s objections regarding the purported “estimates,”
`
`“understandings,” and “beliefs” in Ex. 2058 have been mollified by the
`
`9
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`Supplemental Declaration of Elizabeth Patton, (Supp. Ex. 2058), which does not
`
`contain such testimony. See Masterimage 3d, IPR2015-00040, Paper 85 at 68.
`
`ANM’s arguments regarding 37 C.F.R. § 11.307 must also be rejected because
`
`ANM did not timely object to Ex. 2058 on that basis. (Compare Paper 52 at 41–45
`
`with Pet.’s MTE at 10–12.) A party may move to exclude evidence only if it
`
`previously objected on those grounds. See 37 C.F.R. § 42.64(b)(1) (“The objection
`
`must identify the grounds for the objection with sufficient particularity to allow
`
`correction in the form of supplemental evidence.”). Because ANM failed to do so,
`
`its motion to exclude under 37 C.F.R. § 11.307 is procedurally improper. See HTC
`
`Corp., IPR2014-01155, Paper 36 at 26 (denying motion to exclude when party did
`
`not previously identify grounds for objection).
`
`Further, 37 C.F.R. § 11.307 provides only that an attorney may not act as an
`
`advocate at a proceeding in which they are a “necessary witness,” i.e., only “where
`
`the proposed testimony . . . is unobtainable elsewhere.” Carta v. Lumbermens Mut.
`
`Cas. Ins. Co., 419 F. Supp. 2d 23, 29 (D. Mass. 2006); see Schiedmayer Celesta
`
`Gmbh v. Piano Factory Grp., No. CANCELLATION 9206121, 2016 WL 8222575,
`
`at *6 (TTAB Dec. 21, 2016) (“A necessary witness is one who offers evidence that
`
`is not available from another source.”). Patton is not a necessary witness as her
`
`testimony is available from other sources. Indeed, the entirety of Patton’s testimony
`
`provides information authenticating various documents, such as prior Miller
`
`10
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`testimony, underlying trial exhibits, and ANM’s websites. All of that information is
`
`available through multiple other avenues, including previous public trial testimony,
`
`(see, e.g., Ex. 2059 at 1285:12–24, et seq.), cross-examination testimony conducted
`
`in this IPR proceeding, (see Ex. 2097), and examination of public websites, see
`
`Universal Safety Response, Inc. v. Secure USA, Inc., No. 08CIV4851LTSDCF, 2010
`
`WL 11595035, at *2 (S.D.N.Y. Apr. 27, 2010) (finding attorney was not necessary
`
`witness because court could take judicial notice of websites and any witness could
`
`perform same internet searches). Thus, ANM’s motion to exclude should be denied.
`
` Exhibit 2059 – Trial Transcript from Dires Case.
`
`ANM fails to prove that Ex. 2059 is inadmissible hearsay. Statements made
`
`by Miller constitute party opponent admissions and, thus, are not hearsay. See
`
`Comput. Sys. Eng'g, Inc. v. Qantel Corp., 740 F.2d 59, 66 (1st Cir. 1984) (admitting
`
`statements of company’s president as statements of a party opponent); FRE
`
`801(d)(2). Further, Ex. 2059 was created and recorded at the time it was presented,
`
`by a court reporter, in publicly filed lawsuit Sleep Number Corp. v. John Baxter, et
`
`al., 12-cv-2899-DF-SER (D. Minn. 2012), on appeal, Sleep Number Corp. v. John
`
`Baxter, et al., 19-1077 (8th Cir. 2019) (“Dires Case”), and thus constitutes a record
`
`of a regularly conducted activity, an exception to hearsay. See FRE 803(6), 901(b).
`
`ANM similarly fails to show that Ex. 2059 is irrelevant. The exhibit provides
`
`record of Miller’s testimony regarding his/ANM’s consulting for PO, ANM’s
`
`11
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`relationship with Dires, and statements made by (and training of) Dires’ salespersons
`
`about the products manufactured by ANM that embody the asserted claims. (See Ex.
`
`2059; see also Exs. 2060-2061 (e.g., Ex. 2061 at 1 instructing to refer to ANM/Dires
`
`collectively).) This testimony is relevant to secondary considerations such as
`
`commercial success and copying, issues central to this proceeding. Lastly, the
`
`exhibit is properly authenticated. PO’s counsel attested to being present during the
`
`testimony provided in Ex. 2059 (and there is no requirement to attest to “have
`
`personal knowledge of the underlying substance” as ANM incredulously submits),
`
`and the testimony therein was transcribed by a court reporter and publicly filed.
`
`(Supp. Ex. 2058 ¶5.) Further, Miller testified in this proceeding that he provided the
`
`testimony and has no reason to question the accuracy of the transcription. (Ex. 2097
`
` Exhibits 2060 – Dires Business Records.
`
`at 102:15–103:5.) ANM’s arguments simply fall flat.
`
`ANM fails to prove Ex. 2060, various training emails created by Dires,
`
`discussing ANM, is inadmissible hearsay. Because Dires is a real party-in-interest
`
`in these proceedings, its statements are attributable to ANM. See Provepharm Inc.
`
`v. Wista Labs. Ltd., IPR2018-00323, Paper 49 at 28–29 (PTAB July 2, 2019)
`
`(attributing real party-in-interest’s statements to petitioner); see also FRE
`
`801(d)(2)(D) (party opponent statement includes statement “made by the party’s
`
`agent or employee on a matter within the scope of that relationship”). Additionally,
`
`12
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`Ex. 2060 is admissible under FRE 803(6). The documents in the exhibit are training
`
`documents created or authorized by Miller and other Dires employees in the regular
`
`course of business, and as detailed below, ANM cannot credibly question their
`
`authenticity.4 See Conoco Inc. v. Dept. of Energy, 99 F.3d 387, 391 (Fed. Cir. 1996)
`
`(noting “business records exception has been construed generously in favor of
`
`admissibility” due to records’ general trustworthiness and need for such evidence).
`
`To establish Ex. 2060’s authenticity, PO need only “produce evidence
`
`sufficient to support a finding that the item is what the proponent claims it is,” see
`
`FRE 901, and notably “the standard for admissibility under [FRE] 901(a) is slight.”
`
`Ericsson v. Intellectual Ventures I LLC, IPR2014-00527, Paper 41 at 12 (PTAB May
`
`18, 2015). PO’s counsel provided the necessary detail in authenticating Ex. 2060 by
`
`explaining that the documents were produced by Dires in the Dires Case. (See Supp.
`
`Ex. 2058 ¶7; see also Ex. 2059 at 1332:3–1340:25 (Miller’s testimony).) ANM
`
`provides no credible reason for questioning the authenticity of Dires’ own training
`
`materials. See Juniper Networks, Inc. v. Chrimar Sys., Inc., IPR2016-01397, Paper
`
`66 at 62–63 (PTAB Dec. 29, 2017) (denying motion to exclude because petitioner
`
`
`4 ANM’s hearsay within hearsay argument fails as it never timely objected on that
`
`ground, (compare Paper 52 at 46 with Pet.’s MTE at 13), and thus exclusion is
`
`improper. See 37 C.F.R. § 42.64(b)(1); HTC Corp., IPR2014-01155, Paper 36 at 26.
`
`13
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`did not provide adequate reason to question exhibit’s authenticity).
`
` Exhibit 2061 – Dires Emails.
`
`For the reasons articulated above with respect to Ex. 2060, Ex. 2061 is also
`
`authenticated and admissible—as party opponent admissions and as business
`
`records—because Dires employees created the emails, they contain information
`
`about ANM, and Dires produced them in the Dires Case. (Supra Section VII; see
`
`also Exhibit 2059 at 1790:15–1792:6, 1356:7–1359:2, 1349:16–1352:2, 1788:2–
`
`1790:7, 1352:3–1353:2, 1353:3–1354:6 (Miller’s testimony).) Further, the emails
`
`contain training directives and sales updates by Dires sales managers based upon
`
`information provided or authorized by Miller, again constituting admissible business
`
`records. See Comcast Cable Comm’n, LLC v. Promptu Sys. Corp., IPR2018-00343,
`
`Paper 56 at 77 (PTAB July 18, 2019) (email updating employees on conduct of
`
` Exhibits 2070–2075 – Infringement Contentions.
`
`business admissible under business records exception).
`
`Ex. 2070–2075 are PO’s district court infringement contention disclosures
`
`and claim charts. Although submitted by PO’s attorneys, they reflect the opinions of
`
`PO’s experts, not a regurgitation of attorney argument. (See Ex. 1055 at 207:5–
`
`210:2; Ex. 1065 at 101:11–22.) It is perfectly valid for an expert to adopt contentions
`
`from district court for purposes of opinions in an IPR proceeding and for the
`
`contentions to be filed with the Board in support of those opinions. See Polygroup
`
`14
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`Ltd. v. Willis Elec. Co., IPR2016-01610, Paper 187 at 10–11 (PTAB Feb. 26, 2018)
`
`(declining to exclude infringement contentions as hearsay where expert had relied
`
`upon them in forming opinions about secondary considerations). Further, the
`
`contentions are not being offered for the truth of the matter asserted—i.e.
`
`infringement by ANM—but rather to show nexus and copying. See Paper 47 at 64–
`
`66.) And the underlying facts in the contentions support PO’s experts’ opinions. See
`
`FRE 703 (underlying facts need not be admissible for expert’s opinion based upon
`
`facts to be admitted). Accordingly, the contentions also do not circumvent the page
`
` Exhibit 2084 – Optimus Emails.
`
`limit or rule on incorporation by reference. See 37 C.F.R. § 42.65(a).
`
`The portions of Ex. 2084 upon which PO relies are admissible as statements
`
`by a party opponent. FRE 801(d)(2). Indeed, the portion of the exhibit that PO cites
`
`is an email from Miller. See Qantel Corp., 740 at 66 (admitting statements of
`
`company’s president as statements of party opponent). (See also Paper 47 at 63;
`
`Paper 78 at 23.) Further, PO’s expert, Messner, cites to the exhibit in his declaration.
`
`(Ex. 2040 ¶33.) See FRE 703 (fact and data providing basis of expert opinion need
`
`not be independently admissible).
`
`CONCLUSION
`
`For the foregoing reasons, PO respectfully requests the Board deny ANM’s
`
`Motion to Exclude Exhibits 2041, 2043–2055, 2058–2061, 2070–2075, and 2084.
`
`15
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`
`Dated: May 6, 2020
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`
`
`
`
`By: /s/Luke Toft
`Luke Toft (Reg. No. 75,311)
`Andrew S. Hansen (pro hac vice)
`Archana Nath (pro hac vice)
`Elizabeth A. Patton (pro hac vice)
`FOX ROTHSCHILD LLP
`222 South Ninth Street, Suite 2000
`Minneapolis, MN 55402-3338
`Telephone: (612) 607-7000
`ltoft@foxrothschild.com
`ahansen@foxrothschild.com
`anath@foxrothschild.com
`epatton@foxrothschild.com
`
`Steven A. Moore (Reg. No. 55,462)
`ZHONG LUN
`1717 Kettner Boulevard, Suite 200
`San Diego, CA 92101
`Telephone: (323) 930-5690
`stevemoore@zhonglun.com
`
`Kecia J. Reynolds (Reg. No. 47,021)
`PILLSBURY WINTHROP SHAW PITTMAN LLP
`1200 Seventeenth Street, NW
`Washington, DC 20036
`Telephone: (202) 663-8000
`kecia.reynolds@pillsburylaw.com
`
`Attorneys for Patent Owner
`Sleep Number Corporation
`
`
`
`16
`
`

`

`Case IRP2019-00514
`Patent 5,904,172
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR § 42.6(e), the undersigned hereby certifies that on May 6,
`
`2020, the foregoing Patent Owner’s Opposition to Petitio

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket